Cargando…

New opioid use and risk of opioid-related adverse events among adults with intellectual and developmental disabilities in Ontario, Canada

BACKGROUND: Individuals with intellectual and developmental disability (IDD) can have a high prevalence of pain, which can be managed with prescription opioids. However, the prevalence of substance use disorder is also high in this population, raising concern about opioid-related adverse events. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Qi, Men, Siyu, Lunsky, Yona, Juurlink, David N., Bronskill, Susan E., Wunsch, Hannah, Gomes, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707500/ https://www.ncbi.nlm.nih.gov/pubmed/36440532 http://dx.doi.org/10.1192/bjo.2022.612

Ejemplares similares

New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
por: Guan, Qi, et al.
Publicado: (2021)

COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada
por: Lunsky, Yona, et al.
Publicado: (2022)

Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2019)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2022)

Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
por: Lunsky, Yona, et al.
Publicado: (2017)

Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
por: Lin, Elizabeth, et al.
Publicado: (2016)

Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019
por: Camden, Andi, et al.
Publicado: (2021)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018)

Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2021)

COVID-19 vaccination rates and related outcomes in adults with intellectual and developmental disabilities (IDD): An application of linked administrative health data to support Ontario’s COVID-19 response.
por: Troke, Natalie, et al.
Publicado: (2022)

COVID-19 testing, infection rates, and related outcomes in adults with intellectual and developmental disabilities (IDD): An application of linked administrative health data to support Ontario’s COVID-19 response.
por: Troke, Natalie, et al.
Publicado: (2022)

Measuring the Burden of Opioid-Related Mortality in Ontario, Canada, During the COVID-19 Pandemic
por: Gomes, Tara, et al.
Publicado: (2021)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
por: Garg, Ria, et al.
Publicado: (2022)

Virtual health care for adult patients with intellectual and developmental disabilities: A scoping review
por: Selick, Avra, et al.
Publicado: (2021)

Association of Preexisting Disability With Severe Maternal Morbidity or Mortality in Ontario, Canada
por: Brown, Hilary K., et al.
Publicado: (2021)

The experiences and attitudes of family caregivers of adults with intellectual and developmental disabilities at different timepoints in the COVID-19 pandemic
por: Tarzi, Gabriel, et al.
Publicado: (2023)

A systematic review of intellectual and developmental disability curriculum in international pre-graduate health professional education
por: Vi, Lisa, et al.
Publicado: (2023)

Suicide Behavior in Persons with Intellectual Disability
por: Merrick, Joav, et al.
Publicado: (2005)

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
por: Kitchen, Sophie A., et al.
Publicado: (2022)

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs
por: Vigod, Simone N., et al.
Publicado: (2016)

Accessibility of Virtual Primary Care for Adults With Intellectual and Developmental Disabilities During the COVID-19 Pandemic: Qualitative Study
por: Selick, Avra, et al.
Publicado: (2022)

Achieving better health for people with intellectual disability: the power of policy
por: Sheehan, Rory, et al.
Publicado: (2018)

Comparison of Emergency Department Use Between Pregnant People With and Without Disabilities in Ontario, Canada
por: Brown, Hilary K., et al.
Publicado: (2023)

Prevalence of intellectual and developmental disabilities among first generation adult newcomers, and the health and health service use of this group: A retrospective cohort study
por: Durbin, Anna, et al.
Publicado: (2019)

Disability and in-hospital breastfeeding practices and supports in Ontario, Canada: a population-based study
por: Brown, Hilary K, et al.
Publicado: (2023)

Organizational attributes of interprofessional primary care for adults with intellectual and developmental disabilities in ontario, Canada: a multiple case study
por: Bobbette, Nicole, et al.
Publicado: (2021)

Greater Opioid Use Among Nursing Home Residents in Ontario, Canada During the First 2 Waves of the COVID-19 Pandemic
por: Maxwell, Colleen J., et al.
Publicado: (2022)

“Can you hear me now?”: a qualitative exploration of communication quality in virtual primary care encounters for patients with intellectual and developmental disabilities
por: Selick, Avra, et al.
Publicado: (2023)

The opioid crisis: past, present and future policy climate in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2017)

Characteristics of Opioid-Users Whose Death Was Related to Opioid-Toxicity: A Population-Based Study in Ontario, Canada
por: Madadi, Parvaz, et al.
Publicado: (2013)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Virtual Education Program to Support Providers Caring for People With Intellectual and Developmental Disabilities During the COVID-19 Pandemic: Rapid Development and Evaluation Study
por: Thakur, Anupam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_md70h9drvtc7qoq9geanlk3kkq